business models AnaptysBio (ANAB)
AnaptysBio’s Jemperli royalty receipts rise after a Sagard financing obligation ends in 2027.
XNAS
Anaptysbio, INC
ANAB
1 article
$1.6B Market cap · 2026-07-31
business models business models 
XNAS
ANAB
1 article
$1.6B Market cap · 2026-07-31
business models AnaptysBio’s Jemperli royalty receipts rise after a Sagard financing obligation ends in 2027.